VOYA INVESTMENT MANAGEMENT LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1068837 ATLANTA, GA

Position in PRAX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$40,920,376

+$31,855,884 QoQ

Shares Held

122,227

+334.4% QoQ

Ownership

0.438%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#43

of 306 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 92% None 8%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. PRAX ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
4	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
5	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
6	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
7	PRAX	Praxis Precision Medicines, Inc. This page	122,227	$40,920,376
8	REGN	Regeneron Pharmaceuticals, Inc.	65,505	$40,844,986

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,920,376	122,227	+334.4%	Shares	Defined	2026-08-12
2026-03-31	$9,064,492	28,134	+106.0%	Shares	Defined	2026-05-12
2025-12-31	$4,024,674	13,655	+177.6%	Shares	Defined	2026-02-12
2025-06-30	$206,843	4,919	-5.9%	Shares	Defined	2025-08-14
2024-12-31	$402,346	5,228	-7.8%	Shares	Defined	2025-05-02
2024-09-30	$326,194	5,669	-2.7%	Shares	Defined	2025-02-07
2024-06-30	$240,880	5,824	-69.7%	Shares	Defined	2025-02-07
2023-03-31	$15,545	19,216	+6.3%	Shares	Defined	2025-02-07
2022-12-31	$43,004	18,069	+44.1%	Shares	Defined	2025-02-07
2022-03-31	$128,012	12,538	0.0%	Shares	Defined	2022-05-16
2021-12-31	$246,998	12,538	+4.9%	Shares	Defined	2022-02-14
2021-09-30	$221,103	11,958	+202.0%	Shares	Defined	2021-11-15
2020-12-31	$217,824	3,959	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.